The in vitro treatment with vitamin D3 is ineffective on the expression of PKC isoenzymes, but decreases further the impaired production of IL-2 in the T lymphocytes of SLE patients

Rheumatology International

Volumn 34, Issue 5, 2014, Pages 717-720

  Czifra, Gabriella ^a   Tóth, Balázs ^a   Kovács, Ildikó ^a   Bíró, Tamás ^a   Griger, Zoltán ^a   Baráth, Sándor ^a   Tarr, Tünde ^a   Zeher, Margit ^a   Sipka, Sándor ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Cytokines; Protein kinase C; SLE

Indexed keywords

COLECALCIFEROL; CORTICOSTEROID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; ISOENZYME; PKC ALPHA; PKC BETA; PKC DELTA; PKC EPSILON; PKC THETA; PKC XI; PROTEIN KINASE C; PROTEIN KINASE C ISOENZYME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CALCITRIOL; IL2 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE TIME EFFECT RELATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; WESTERN BLOTTING; AGED; CASE CONTROL STUDY; CELL CULTURE; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECTS; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CALCITRIOL; CASE-CONTROL STUDIES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; HUMANS; INTERLEUKIN-2; ISOENZYMES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROTEIN KINASE C; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84901344676     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2751-y     Document Type: Article

References (18)

1. Biró T, Griger Z, Kiss E et al (2004) Abnormal cell specific expression of certain protein kinase C isoenzymes in peripheral mononuclear cells of patients with systemic lupus erythematosus: effect of corticosteroid application. Scand J Immunol 60:421-428 (Pubitemid 39331498)
2. Sipka S (2011) Adenosine inhibits the release of arachidonic acid in activated human peripheral mononuclear cells. A proposed model for physiologic and pathologic regulation in systemic lupus erythematosus. Sci World J 11:972-980
3. Perl A (2010) Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity 7(43):1-6
4. Kyttaris VC, Krishnan S, Tsokos GS et al (2006) Systems biology in systemic lupus erythematosus; integrating genes, biology and immune functions. Autoimmunity 39:705-709 (Pubitemid 44964373)
5. Jury EC, Kabouridis PS, Abba A et al (2003) Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus. Arthr Rheum 48:1343-1354 (Pubitemid 36554533)
6. Griger Z, Tóth BI, Baráth S et al (2011) Different effects of Bortezomib on the expressions of various protein kinase C isoenzymes in T cells of patients with systemic lupus erythematosus and in Jurkat cells. Scand J Immunol 75:243-248
7. 3 receptors by blocking ubiquitin/proteosome mediated degradation in human skin. Mol Endocrinol 13:1689-1694
8. Borba VZ, Vieira JG, Kasamatsu T et al (2009) Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 20:427-433
9. Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C et al (2012) Vitamin status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus 5:477-484
10. Hochberg M (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725-1734
11. Szodoray P, Nakken B, Gaál J et al (2008) The complex role of vitamin D in autoimmune diseases. Scand J Immunol 68:261-269
12. 3 down-regulates intracellular Toll like receptor 9 expression and Toll like receptor 9 induced IL-6 production in human monocytes. Rheumatology 49:1466-1471
13. Zöld É, Szodoray P, Nakken P et al (2011) Alfacalcidol treatment restores derailed
14. Immune-regulation in patients with undifferentiated connective tissue disease. Autoimmunity Rev 10: 155-162
15. Boyan BD, Schwartz Z (2004) Rapid vitamin D dependent PKC signaling shares features with estrogen dependent PKC signaling in cartilage and bone. Steroids 69:591-597 (Pubitemid 39013493)
16. 3. J Cell Physiol 167:380-393
17. Holick MU, Binkley NC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. Clin Endocrinol Metab 96:1911-1930
18. Wejse C (2009) Vitamin D supplementary treatment for tuberculosis-double blind randomized, placebo controlled trial. Am J Resp Crit Care Med 179:843-850